Life Saving Drugs Program resources – Fabry disease

A collection of resources for health professionals to help people with Fabry disease access the following drugs under the Life Saving Drugs Program: agalsidase alfa (Replagal®), agalsidase beta (Fabrazyme®) and migalastat (Galafold®).

This collection contains guidelines, forms and documents related to accessing the following drugs under the Life Saving Drugs Program. Click to view the product information for each drug on the Therapeutic Goods Administration website:

Guidelines

Forms

Patient resources

Medicines review documents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Collection
Audience:
Health sector

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.